AIS patients had significantly higher plasma levels of ceramides (C14-20), ceramides (>C22), were significantly lower in AIS patients. Higher levels of Cer were significantly associated with poor functional outcomes. Here, CBLN1 is linked to androgen insensitivity syndrome.